Can Fite BioPharma Ltd (CANF)

[midastouch017]

Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on June 4th

Business Wire Business Wire•June 3, 2020

Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on June 4th
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced CEO Dr. Pnina Fishman will share insight into the company’s recent developments and upcoming milestones during an investor webinar on Thursday, June 4th, 2020 at 11:00 a.m. ET. A live Q&A session with Dr. Fishman will follow the presentation.

To participate in the webinar, please register at: https://www.redchip.com/corporate/webinar_register/61

Questions can be pre-submitted to [e-mail] or online during the event.

The webinar will be accessible through the News/Events section of Can-Fite’s website at www.canfite.com, where it will also be archived for a period of time.

https://finance.yahoo.com/news/fite-biopharma-hold-investor-webinar-110000393.html